GB201720101D0 - Novel compounds and pharmaceutical compositions thereof for the treatment of diseases - Google Patents

Novel compounds and pharmaceutical compositions thereof for the treatment of diseases

Info

Publication number
GB201720101D0
GB201720101D0 GBGB1720101.3A GB201720101A GB201720101D0 GB 201720101 D0 GB201720101 D0 GB 201720101D0 GB 201720101 A GB201720101 A GB 201720101A GB 201720101 D0 GB201720101 D0 GB 201720101D0
Authority
GB
United Kingdom
Prior art keywords
diseases
treatment
pharmaceutical compositions
novel compounds
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1720101.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galapagos NV
Original Assignee
Galapagos NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos NV filed Critical Galapagos NV
Priority to GBGB1720101.3A priority Critical patent/GB201720101D0/en
Publication of GB201720101D0 publication Critical patent/GB201720101D0/en
Priority to CA3084090A priority patent/CA3084090A1/en
Priority to MX2020005423A priority patent/MX2020005423A/en
Priority to BR112020010364-0A priority patent/BR112020010364A2/en
Priority to ES18811769T priority patent/ES2908283T3/en
Priority to SG11202004925QA priority patent/SG11202004925QA/en
Priority to MA051200A priority patent/MA51200A/en
Priority to AU2018374456A priority patent/AU2018374456B2/en
Priority to HUE18811769A priority patent/HUE057581T2/en
Priority to JP2020529717A priority patent/JP7326276B2/en
Priority to PCT/EP2018/082537 priority patent/WO2019105886A1/en
Priority to US16/768,825 priority patent/US11339166B2/en
Priority to CN201880077841.9A priority patent/CN111433200B/en
Priority to EP18811769.1A priority patent/EP3717471B1/en
Priority to DK18811769.1T priority patent/DK3717471T3/en
Priority to PL18811769T priority patent/PL3717471T3/en
Priority to RU2020121645A priority patent/RU2782375C2/en
Priority to PT188117691T priority patent/PT3717471T/en
Priority to KR1020207019014A priority patent/KR20200096571A/en
Priority to ARP180103512A priority patent/AR113863A1/en
Priority to TW107142872A priority patent/TW201930301A/en
Priority to IL274938A priority patent/IL274938B2/en
Priority to PH12020550725A priority patent/PH12020550725A1/en
Priority to CONC2020/0008066A priority patent/CO2020008066A2/en
Priority to ZA2020/04025A priority patent/ZA202004025B/en
Priority to CY20221100182T priority patent/CY1125044T1/en
Priority to US17/719,653 priority patent/US20220340581A1/en
Ceased legal-status Critical Current

Links

GBGB1720101.3A 2017-12-02 2017-12-02 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases Ceased GB201720101D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GBGB1720101.3A GB201720101D0 (en) 2017-12-02 2017-12-02 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
KR1020207019014A KR20200096571A (en) 2017-12-02 2018-11-26 New compounds for the treatment of diseases and pharmaceutical compositions thereof
CN201880077841.9A CN111433200B (en) 2017-12-02 2018-11-26 Compounds and pharmaceutical compositions for the treatment of diseases
DK18811769.1T DK3717471T3 (en) 2017-12-02 2018-11-26 NEW COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREFORE FOR THE TREATMENT OF DISEASES
BR112020010364-0A BR112020010364A2 (en) 2017-12-02 2018-11-26 compounds and pharmaceutical compositions thereof for the treatment of diseases
ES18811769T ES2908283T3 (en) 2017-12-02 2018-11-26 New compounds and pharmaceutical compositions thereof for the treatment of diseases
SG11202004925QA SG11202004925QA (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
MA051200A MA51200A (en) 2017-12-02 2018-11-26 NEW COMPOUNDS AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES
AU2018374456A AU2018374456B2 (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
HUE18811769A HUE057581T2 (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
JP2020529717A JP7326276B2 (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
PCT/EP2018/082537 WO2019105886A1 (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
US16/768,825 US11339166B2 (en) 2017-12-02 2018-11-26 Compounds and pharmaceutical compositions thereof for the treatment of diseases
CA3084090A CA3084090A1 (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP18811769.1A EP3717471B1 (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
MX2020005423A MX2020005423A (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases.
PL18811769T PL3717471T3 (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
RU2020121645A RU2782375C2 (en) 2017-12-02 2018-11-26 New compounds and their pharmaceutical compositions for treatment of diseases
PT188117691T PT3717471T (en) 2017-12-02 2018-11-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
ARP180103512A AR113863A1 (en) 2017-12-02 2018-11-29 COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES
TW107142872A TW201930301A (en) 2017-12-02 2018-11-30 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL274938A IL274938B2 (en) 2017-12-02 2020-05-26 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
PH12020550725A PH12020550725A1 (en) 2017-12-02 2020-05-28 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
CONC2020/0008066A CO2020008066A2 (en) 2017-12-02 2020-06-30 New compounds and their pharmaceutical compositions for the treatment of diseases
ZA2020/04025A ZA202004025B (en) 2017-12-02 2020-07-01 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
CY20221100182T CY1125044T1 (en) 2017-12-02 2022-03-02 NEW COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES
US17/719,653 US20220340581A1 (en) 2017-12-02 2022-04-13 Compounds and pharmaceutical compositions thereof for the treatment of diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1720101.3A GB201720101D0 (en) 2017-12-02 2017-12-02 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases

Publications (1)

Publication Number Publication Date
GB201720101D0 true GB201720101D0 (en) 2018-01-17

Family

ID=60950383

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1720101.3A Ceased GB201720101D0 (en) 2017-12-02 2017-12-02 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases

Country Status (2)

Country Link
AR (1) AR113863A1 (en)
GB (1) GB201720101D0 (en)

Also Published As

Publication number Publication date
AR113863A1 (en) 2020-06-17

Similar Documents

Publication Publication Date Title
ZA202004025B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201720163D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis B
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
IL271807A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
IL261444A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
IL279397A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL288375A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL274578A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
IL272601A (en) Pharmaceutical compositions for the treatment of ophthalmic conditions
ZA202002166B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL270927B (en) 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL257336B (en) Compounds and pharmaceutical compositions for prevention or treatment of parasitic diseases
IL285751A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL272495A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
HUE053866T2 (en) Pharmaceutical composition for the treatment of constipation
GB201720101D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201817344D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201817343D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201809836D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201814764D0 (en) Pharmaceutical compositions for the treatment of proteinopathies
GB201714241D0 (en) Pharmaceutical compositions for the treatment of proteinopathies
GB201817346D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of diseases
GB201718838D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
GB201712742D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)